Stereotactic Body Radiation Therapy SBRT

RADIATION2 trials

Sponsors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo

Conditions

Breast CancerEGF-R Positive Non-Small Cell Lung CancerEGFR Exon 19 DeletionEGFR Exon 21 MutationEGFR G719XNon Small Cell Lung Cancer

Phase 2

Study of Stereotactic Radiotherapy for Breast Cancer

TerminatedNCT03043794

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsBreast Cancer

Start: 2017-08-01End: 2023-10-22Updated: 2024-09-19

Unknown Phase

Study to Evaluate SBRT for EGFR Mutant NSCLC Patients Receiving Osimertinib (CULTRO)

Not yet recruitingNCT05998993

Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento AnguloEGFR Exon 19 Deletion, EGFR Exon 21 Mutation, EGFR G719X +2

Start: 2023-11-30End: 2028-11-30Target: 35Updated: 2023-08-21

Related Papers

Single fraction ablative preoperative radiation treatment for early-stage breast cancer: the CRYSTAL study – a phase I/II clinical trial protocol

BMC Cancer2022-04-0217 citations